Polar Capital Holdings PLC Pacira Bio Sciences, Inc. Transaction History

Polar Capital Holdings PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 13, 2023	SELL	$36.12 - $47.5 $140,506 - $184,775	-3,890 Reduced 30.89%	8,705 $348,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $47.5 $140,506 - $184,775	-3,890 Reduced 30.89%	8,705 $348,000
Q1 2023 Dec 13, 2023	BUY	$35.53 - $43.38 $138,211 - $168,748	3,890 Added 44.69%	12,595 $514,000
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $204,960 - $235,560	4,000 Added 46.54%	12,595 $670,000
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $270,322 - $428,610	5,250 Added 156.95%	8,595 $501,000
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $841,800 - $1.07 Million	-14,023 Reduced 80.74%	3,345 $255,000
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $1.03 Million - $1.22 Million	17,368 New	17,368 $1.05 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.